PL3400000T3 - Sposoby podawania angiotensyny ii - Google Patents

Sposoby podawania angiotensyny ii

Info

Publication number
PL3400000T3
PL3400000T3 PL17736407.2T PL17736407T PL3400000T3 PL 3400000 T3 PL3400000 T3 PL 3400000T3 PL 17736407 T PL17736407 T PL 17736407T PL 3400000 T3 PL3400000 T3 PL 3400000T3
Authority
PL
Poland
Prior art keywords
methods
administering angiotensin
angiotensin
administering
Prior art date
Application number
PL17736407.2T
Other languages
English (en)
Inventor
George Tidmarsh
Lakhmir Chawla
Original Assignee
La Jolla Pharma, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59273945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3400000(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by La Jolla Pharma, Llc filed Critical La Jolla Pharma, Llc
Publication of PL3400000T3 publication Critical patent/PL3400000T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G01N2410/02—Angiotensins; Related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
PL17736407.2T 2016-01-07 2017-01-06 Sposoby podawania angiotensyny ii PL3400000T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276171P 2016-01-07 2016-01-07
US201662347292P 2016-06-08 2016-06-08
PCT/US2017/012485 WO2017120438A1 (en) 2016-01-07 2017-01-06 Methods for administering angiotensin ii

Publications (1)

Publication Number Publication Date
PL3400000T3 true PL3400000T3 (pl) 2024-04-22

Family

ID=59273945

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17736407.2T PL3400000T3 (pl) 2016-01-07 2017-01-06 Sposoby podawania angiotensyny ii

Country Status (11)

Country Link
US (3) US10406201B2 (pl)
EP (1) EP3400000B1 (pl)
JP (1) JP2019501201A (pl)
KR (2) KR20250174727A (pl)
AU (2) AU2017205168A1 (pl)
BR (1) BR112018013847A2 (pl)
CA (1) CA3010781A1 (pl)
ES (1) ES2973280T3 (pl)
PL (1) PL3400000T3 (pl)
TW (1) TW201733610A (pl)
WO (1) WO2017120438A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
AU2017205168A1 (en) 2016-01-07 2018-08-16 La Jolla Pharma, Llc Methods for administering angiotensin II
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
US20220406429A1 (en) * 2019-11-04 2022-12-22 The Regents Of The University Of California Artificial Intelligence Enabled Control of Hemodynamics in Surgery Patients

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
CA2448051A1 (en) 2001-06-04 2002-12-12 Human Genome Sciences, Inc. Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
ATE507243T1 (de) 2005-09-29 2011-05-15 Fibrogen Inc Verfahren zur senkung des blutdrucks
CN101351215A (zh) 2005-12-30 2009-01-21 霍华德·弗洛里实验生理学及医学研究所 治疗方法
CA2655144A1 (en) * 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008059062A1 (en) 2006-11-17 2008-05-22 Da Volterra Colonic delivery using zn/pectin beads with a eudragit coating.
MX2011005672A (es) 2008-11-28 2011-06-20 Abbott Lab Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
KR20130026504A (ko) 2010-07-14 2013-03-13 큠버랜드 에멀징 테크놀로지스 아이앤씨 트롬복산-a2 수용체 길항제를 이용한 간신증후군 및 간성뇌증의 치료방법
CN105592855A (zh) 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
MX2017000306A (es) 2014-07-08 2017-07-10 La Jolla Pharma Co Metodos para tratar hipotension.
AU2017205168A1 (en) 2016-01-07 2018-08-16 La Jolla Pharma, Llc Methods for administering angiotensin II
KR20180108630A (ko) 2016-01-07 2018-10-04 라 졸라 파마슈티칼 컴파니 혈관수축제의 투여 방법
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法

Also Published As

Publication number Publication date
WO2017120438A1 (en) 2017-07-13
US10406201B2 (en) 2019-09-10
AU2017205168A1 (en) 2018-08-16
US20210030834A1 (en) 2021-02-04
BR112018013847A2 (pt) 2018-12-18
ES2973280T3 (es) 2024-06-19
JP2019501201A (ja) 2019-01-17
EP3400000B1 (en) 2023-12-06
EP3400000A4 (en) 2019-07-31
EP3400000A1 (en) 2018-11-14
KR20180108639A (ko) 2018-10-04
US20210187058A1 (en) 2021-06-24
KR20250174727A (ko) 2025-12-12
TW201733610A (zh) 2017-10-01
US11219662B2 (en) 2022-01-11
US20170224761A1 (en) 2017-08-10
CA3010781A1 (en) 2017-07-13
AU2024201059A1 (en) 2024-03-07

Similar Documents

Publication Publication Date Title
SG10201912792YA (en) Therapeutic compounds and methods
SG10201912416QA (en) Therapeutic agents
PL3132034T3 (pl) Środek terapeutyczny
GB201509893D0 (en) Therapeutic agents
GB201616839D0 (en) Therapeutic compounds
GB201517263D0 (en) Therapeutic agents
ZA201502204B (en) Barrier
GB201410816D0 (en) Therapeutic agents
GB201415569D0 (en) Therapeutic Compounds
ZA201805046B (en) Therapeutic compounds
GB201410815D0 (en) Therapeutic agents
GB201410216D0 (en) Therapeutic
GB201509885D0 (en) Therapeutic agents
GB201410817D0 (en) Therapeutic agents
GB201509888D0 (en) Therapeutic agents
GB201617339D0 (en) Therapeutic compounds
IL263821A (en) Medicinal compounds
GB201513299D0 (en) Therapeutic agents
GB201510637D0 (en) Therapeutic
GB201416273D0 (en) Therapeutic compounds
GB2538767B (en) Coffin
SG11201700059WA (en) Therapeutic agent for keratoconjunctive disorder
GB201521767D0 (en) Therapeutic agents
GB201517264D0 (en) Therapeutic agents
GB201410334D0 (en) Therapeutic